740649
Last Update Posted: 2009-03-31
Recruiting has ended
Males accepted | 20 Years-45 Years |
74 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016
This is a single ascending dose study of HSD-016 to provide the initial assessment of the safety, tolerability, how the drug is absorbed and eliminated, and it's effect on the body in Japanese male subjects.
Eligibility
Relevant conditions:
Healthy Subjects
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov